SEC 13F Intelligence

Hudson Canyon Capital Management / BIIB

Hudson Canyon Capital Management’s Biogen Inc Position

Does Hudson Canyon Capital Management own Biogen Inc (BIIB)? Not currently — the last reported position was 8.0K shares worth $2M in Q2 2024; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$2M
Q2 2024
Shares
8.0K
% of Portfolio
+1.26%
Quarters Held
5
position exited

Position History BIIB

Reported value by quarter
Q2 ’23: $1MQ2 ’23Q3 ’23: $2MQ3 ’23Q4 ’23: $2MQ4 ’23Q1 ’24: $2MQ1 ’24Q2 ’24: $2MQ2 ’24filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20248.0K$2M+1.26%
Q1 20247.7K$2M+1.07%
Q4 20237.7K$2M+1.45%
Q3 20237.7K$2M+1.62%
Q2 20234.8K$1M+1.08%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Hudson Canyon Capital Management’s full portfolio or all institutional holders of BIIB.